How challenging can it be to treat Behçet uveitis?
M Oray, Z Cebeci, N Kir… - Saudi Journal of …, 2022 - journals.lww.com
A 20-year-old male Behçet uveitis (BU) patient presented with visual acuities (VAs) of hand
movement in OD and counting fingers at 1 m in OS following treatment with corticosteroid …
movement in OD and counting fingers at 1 m in OS following treatment with corticosteroid …
[PDF][PDF] Meeting report Highlights of the 2nd EUVAS Vasculitis Course
2nd EUVAS Vasculitis Course/G. Emmi et al. activating FcG receptors abrogates the
disease, but even more interestingly, if the inhibitory receptor FcGR3B is knocked out, the …
disease, but even more interestingly, if the inhibitory receptor FcGR3B is knocked out, the …
[HTML][HTML] Indications, response, and side effects of biologic treatment in Behçet's disease: an 8-year study with follow-up
S Shenavandeh, E Aflaki, MR Jahromi… - …, 2024 - ncbi.nlm.nih.gov
Results The most common indications for starting biologic agents were ophthalmic (68.2%),
parenchymal brain involvement (15.9%), and arthritis (11.4%). Improvement was observed …
parenchymal brain involvement (15.9%), and arthritis (11.4%). Improvement was observed …
[HTML][HTML] α 干扰素在白塞综合征中的应用进展
严冬， 郑文洁 - Journal of Peking University (Health Sciences), 2020 - ncbi.nlm.nih.gov
!! 白塞综合征(^ 8? D8> 3F4: 76@ 8,^ J) 是一种慢性复发性自身免疫性疾病,
其病理基础为血管炎, 可累及多脏器, 如皮肤, 黏膜, 关节, 眼, 还可累及心脏大血管 …
其病理基础为血管炎, 可累及多脏器, 如皮肤, 黏膜, 关节, 眼, 还可累及心脏大血管 …
Biological therapies that target inflammatory cytokines to treat uveitis
A Reddy, F Muhammad, DJ Lee - Advances in the Diagnosis and …, 2018 - books.google.com
Uveitis is a leading cause of blindness that presents a considerable challenge given that our
understanding of the mechanisms of disease is still evolving. Both innate and adaptive …
understanding of the mechanisms of disease is still evolving. Both innate and adaptive …
Microvascular changes in the recurrent cystoid macular edema secondary to posterior noninfectious uveitis on optical coherence tomography angiography
V Albano, S Guerriero, C Furino, G Sborgia… - International …, 2022 - Springer
Background Posterior uveitis represents the second most frequent type of uveitis (15–30% of
all uveitis). Noninfectious posterior uveitis complicated with secondary cystoid macular …
all uveitis). Noninfectious posterior uveitis complicated with secondary cystoid macular …
[PDF][PDF] 解读欧洲抗风湿病联盟关于白塞葡萄膜炎治疗的最新建议
赵潺， 张美芬 - 中华眼科医学杂志(电子版), 2018 - medi-guide.meditool.cn
白塞葡萄膜炎是国人最为常见的后葡萄膜炎或全葡萄膜炎类型之一, 其临床预后较差,
致盲率较高, 是葡萄膜炎领域的挑战之一. 白塞葡萄膜炎的治疗方法主要包括糖皮质激素 …
致盲率较高, 是葡萄膜炎领域的挑战之一. 白塞葡萄膜炎的治疗方法主要包括糖皮质激素 …
Disease Management
V Hamuryudan, I Kötter, H Tüzün - Behçet Syndrome, 2020 - Springer
The aim of treatment is suppression of symptoms and prevention of organ damage.
Immunosuppressives constitute the mainstay of treatment. Male sex, young age, and short …
Immunosuppressives constitute the mainstay of treatment. Male sex, young age, and short …
[PDF][PDF] Behçet's disease: A Narrative Review of Clinical Diagnosis and Treatment
Behçet's disease is characterized with recurrent attacks of inflammation that are driven by
systemic vasculitis without any clearly demonstrated triggering mechanism. It is more …
systemic vasculitis without any clearly demonstrated triggering mechanism. It is more …
An Overview of Conventional and Recent Treatment Options for Behcet's Disease
K Cetin Gedik, M Romano, RA Berard… - … Treatment Options in …, 2020 - Springer
Purpose of review Behcet's disease (BD) is a multi-system inflammatory disorder
characterized by a relapsing–remitting course. Several treatment modalities with different …
characterized by a relapsing–remitting course. Several treatment modalities with different …